- Home
- FRSX vs MTNB Comparison
FRSX vs MTNB Comparison
Compare FRSX & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRSX | MTNB |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 5.2M |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FRSX | MTNB |
|---|---|---|
| Price | $1.55 | $0.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 315.6K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,750.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.31 | $0.48 |
| 52 Week High | $3.00 | $3.09 |
Technical Indicators
Market Signals| Indicator | FRSX | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 58.41 |
| Support Level | $0.83 | $0.55 |
| Resistance Level | $2.27 | $0.78 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 23.12 | 74.18 |
Price Performance
Historical ComparisonAbout FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.